2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Diffusion Weighted Imaging
Diffusion Weighted Imaging (DWI) plays a pivotal role in cancer research by offering insights into tissue microstructure and cellular density. In oncology, DWI is particularly valuable for detecting and characterizing tumors, assessing treatment response, and predicting outcomes. By measuring the random motion of water molecules within tissues, DWI can identify areas of restricted diffusion, indicative of cellularity and tumor presence. Moreover, DWI can aid in differentiating between benign and malignant lesions, guiding treatment decisions, and monitoring therapeutic efficacy. Its non-invasive nature and ability to provide functional information make DWI an indispensable tool in cancer imaging, enhancing our understanding of tumor biology and facilitating personalized patient care. Ongoing advancements in DWI techniques and image analysis continue to refine its utility in cancer research and clinical practice.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China